HRG-1 enhances cancer cell invasive potential and couples glucose metabolism to cytosolic/extracellular pH gradient regulation by the vacuolar-H + ATPase

Oncogene

Volumn 33, Issue 38, 2014, Pages 4653-4663

  Fogarty, F M ^a   O'Keeffe, J ^a   Zhadanov, A ^b   Papkovsky, D ^b   Ayllon, V ^a,c   O'Connor, R ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b BioSciences Institute   (Ireland)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

glucose metabolism; HRG 1; IGF 1; pH; V ATPase

Indexed keywords

GELATINASE A; GELATINASE B; GLUCOSE; GLUCOSE TRANSPORTER 1; HEMOPROTEIN; HRG 1 PROTEIN, HUMAN; HRG-1 PROTEIN, HUMAN; LACTIC ACID; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SLC2A1 PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE; CYTOSOL; EXTRACELLULAR FLUID; HUMAN; MCF 7 CELL LINE; METABOLISM; PH; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR INVASION;

CELL MEMBRANE; CYTOSOL; EXTRACELLULAR FLUID; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HEMEPROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; NEOPLASM INVASIVENESS; PROTEIN TRANSPORT; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84885523683     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.403     Document Type: Article

References (39)

1. Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011; 11: 671-677.
2. Cardone Ra Casavola V, Reshkin SJ. The role of disturbed pH dynamics and the Na\+/H\+ exchanger in metastasis. Nat Rev Cancer 2005; 5: 786-795.
3. Swietach P, Hulikova A, Vaughan-Jones R, Harris A. New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene 2010; 29: 6509-6521.
4. Chiche J, Fur YL, Vilmen C, Frassineti F, Daniel L, Halestrap AP et al. In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: Key role of the monocarboxylate transporterMCT4, for inducing an alkaline intracellular pH. Int J Cancer 2011; 130: 1511-1520.
5. Hernandez A, Serrano-Bueno G, Perez-Castineira RJ, Serrano A. Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer. Curr Pharm Des 2012; 18: 1383-1394.
6. Toei M, Saum R, Forgac M. Regulation and isoform function of the V-ATPases. Biochemistry 2010; 49: 4715-4723.
7. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 2007; 8: 917-929.
8. Wagner Ca Finberg KE, Breton S, Marshansky V, Brown D, Geibel JP. Renal vacuolar H\+-ATPase. Physiol Rev 2004; 84: 1263-1314.
9. Toyomura T, Murata Y, Yamamoto A, Oka T, Sun-Wada G-H, Wada Y et al. From lysosomes to the plasma membrane: localization of vacuolar-type H\+-ATPase with the a3 isoform during osteoclast differentiation. J Biol Chem 2003; 278: 22023-22030.
10. Pastor-Soler N, Piétrement C, Breton S. Role of acid/base transporters in the male reproductive tract and potential consequences of their malfunction. Physiol 2005; 20: 417-428.
11. Hinton A, Sennoune SR, Bond S, Fang M, Reuveni M, Sahagian GG et al. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. J Biol Chem 2009; 284: 16400-16408.
12. Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ, Vacuolar-type H. (\+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol Cell Physiol 1993; 265: C1015-C1029.
13. Sennoune SR, Bakunts K, Martńez GM, Chua-Tuan JL, Kebir Y, Attaya MN et al. Vacuolar H\+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 2004; 286: C1443-C1452.
14. Martńez-Zaguilán R, Raghunand N, Lynch RM, Bellamy W, Martinez GM, Rojas B et al. pH and drug resistance. IFunctional expression of plasmalemmal V-type H\+-ATPase in drug-resistant human breast carcinoma cell lines. Biochem Pharmacol 1999; 57: 1037-1046.
15. Nishisho T, Hata K, Nakanishi M, Morita Y, Sun-Wada GH, Wada Y et al. The a3 isoform vacuolar type H\+-ATPase promotes distant metastasis in the mouse B16 melanoma cells. Mol Cancer Res 2011; 9: 845-855.
16. Pérez-Sayáns M, Suárez-Peñ aranda J, Barros-Angueira F, Diz P, Gándara-Rey J, Garcá-Garcá A. An update in the structure, function, and regulation of V-ATPases: the role of the C subunit. Braz J Biol 2012; 72: 189-198.
17. Parra KJ, Kane PM. Reversible association between the V1and V0 domains of yeast vacuolar H\+-ATPase is an unconventional glucose-induced effect. Mol Cell Biol 1998; 18: 7064-7074.
18. Beyenbach KW, Wieczorek H. The V-type H\+ ATPase: molecular structure and function, physiological roles and regulation. J Exper Biol 2006; 209: 577-589.
19. Sautin YY, Lu M, Gaugler A, Zhang L, Gluck SL. Phosphatidylinositol 3-kinasemediated effects of glucose on vacuolar H\+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol Cell Biol 2005; 25: 575-589.
20. Su Y, Zhou A, Al-Lamki RS, Karet FE. The a-subunit of the V-type H\+-ATPase interacts with phosphofructokinase-1 in humans. J Biol Chem 2003; 278: 20013-20018.
21. Lu M. The glycolytic enzyme aldolase mediates assembly, expression, and activity of vacuolar H\+-ATPase. J Biol Chem 2004; 279: 8732-8739.
22. O'Callaghan KM, Ayllon V, O'Keeffe J, Wang Y, Cox OT, Loughran G et al. Hemebinding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H\+-ATPase to control endosomal pH and receptor trafficking. J Biol Chem 2010; 285: 381-391.
23. Thomsen P, Rudenko O, Berezin V, Norrild B. The HPV-16 E5 oncogene and bafilomycin A(1) influence cell motility. Biochim Biophys Acta 1999; 1452: 285-295.
24. Spugnini EP, Citro G, Fais S. Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy. J Exper Clin Cancer Res 2010; 29: 44.
25. Kubota S, Seyama Y. Overexpression of vacuolar ATPase 16-kDa subunit in 10T1/2 fibroblasts enhances invasion with concomitant induction of matrix metalloproteinase-2. Biochem Biophys Res Commun 2000; 278: 390-394.
26. Dechant R, Binda M, Lee SS, Pelet S, Winderickx J, Peter M. Cytosolic pH is a second messenger for glucose and regulates the PKA pathway through V-ATPase. EMBO J 2010; 29: 2515-2526.
27. Clarke JF, Young P, Yonezawa K, Kasuga M, Holman G. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J 1994; 300(Pt 3): 631.
28. Samih N, Hovsepian S, Aouani A, Lombardo D, Fayet G. Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation. Endocrinology 2000; 141: 4146-4155.
29. Martńez-Munõz Ga Kane P. Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast. J Biol Chem 2008; 283: 20309-20319.
30. Yanatori I, Tabuchi M, Kawai Y, Yasui Y, Akagi R, Kishi F. Heme and non-heme iron transporters in non-polarized and polarized cells. BMC Cell Biol 2010; 11: 39.
31. Balgi AD, Diering GH, Donohue E, Lam KKY, Fonseca BD, Zimmerman C et al. Regulation of mTORC1 signaling by pH. PLoS One 2011; 6: e21549.
32. Murakami T, Shibuya I, Ise T, Chen ZS, Akiyama S, Nakagawa M et al. Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance. Int J Cancer 2001; 93: 869-874.
33. Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M et al. Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J Pathol 1999; 185: 324-330.
34. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Rey JMG, Garcia-Garcia A. V-ATPase inhibitors and implication in cancer treatment. Cancer Treat Rev 2009; 35: 707-713.
35. Sennoune RS, Martinez-Zaguilan R. Vacuolar H-ATPase signaling pathway in cancer. Curr Protein Pept Sci 2012; 13: 152-163.
36. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
37. Lu X, Qin W, Li J, Tan N, Pan D, Zhang H et al. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 2005; 65: 6843-6849.
38. Nilsson C, Kågedal K, Johansson U, Ollinger K. Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. Methods Cell Sci 2003; 25: 185-194.
39. Zhdanov AV, Dmitriev RI, Golubeva AV, Gavrilova SA, Papkovsky DB. Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells. Biochim Biophys Acta 2013; 1830: 3553-3569.